Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy
- PMID: 24447612
- DOI: 10.1016/j.eplepsyres.2013.12.015
Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy
Abstract
Background: Over the last few years autoantibodies against neuronal proteins have been identified in several forms of autoimmune encephalitis and epilepsy. NMDA receptor (NMDAR) and voltage gated potassium channel (VGKC) complex antibodies are mainly associated with limbic encephalitis (LE) whereas glutamic acid decarboxylase antibodies (GADA) and anticardiolipin (ACL) antibodies are more commonly detected in patients with chronic epilepsy. Clinical features vary between these antibodies suggesting the specificity of different neuronal antibodies in seizures.
Methods: Serum samples of 14 GADA positive and 24 ACL positive patients with refractory epilepsy were analyzed for the presence of VGKC or NMDAR antibodies.
Results: No positive VGKC or NMDAR antibodies were found in these patients.
Conclusions: The results confirm the different significance of these neuronal antibodies in seizure disorders. Different autoantibodies have different significance in seizures and probably have different pathophysiological mechanisms of actions.
Keywords: Autoimmune encephalitis; Neuronal antibody; New-onset epilepsy; Polyautoimmunity; Refractory epilepsy; Seizure.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Serum antibodies in epilepsy and seizure-associated disorders.Neurology. 2005 Dec 13;65(11):1730-6. doi: 10.1212/01.wnl.0000187129.66353.13. Neurology. 2005. PMID: 16344514
-
Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.Epilepsia. 2016 May;57(5):823-31. doi: 10.1111/epi.13356. Epub 2016 Mar 21. Epilepsia. 2016. PMID: 26996997 Free PMC article.
-
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.Ann Neurol. 2010 Apr;67(4):470-8. doi: 10.1002/ana.21917. Ann Neurol. 2010. PMID: 20437582
-
Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.Seizure. 2013 Mar;22(2):136-40. doi: 10.1016/j.seizure.2012.12.013. Epub 2013 Jan 11. Seizure. 2013. PMID: 23318046 Review.
-
Autoantibodies and epilepsy.Epilepsia. 2011 May;52 Suppl 3:18-22. doi: 10.1111/j.1528-1167.2011.03031.x. Epilepsia. 2011. PMID: 21542841 Review.
Cited by
-
Autoimmune Encephalitis in Children: From Suspicion to Diagnosis.Cureus. 2021 Feb 12;13(2):e13307. doi: 10.7759/cureus.13307. Cureus. 2021. PMID: 33732562 Free PMC article. Review.
-
Neurological autoantibodies in drug-resistant epilepsy of unknown cause.Ir J Med Sci. 2018 Nov;187(4):1057-1063. doi: 10.1007/s11845-018-1777-2. Epub 2018 Mar 9. Ir J Med Sci. 2018. PMID: 29524102
-
Immunotherapy by targeting of VGKC complex for seizure control and prevention of cognitive impairment in a mouse model of epilepsy.Mol Med Rep. 2018 Jul;18(1):169-178. doi: 10.3892/mmr.2018.9004. Epub 2018 May 9. Mol Med Rep. 2018. PMID: 29749462 Free PMC article.
-
Outcome of Encephalitis in Pediatric Intensive Care Unit.Indian J Pediatr. 2016 Oct;83(10):1098-103. doi: 10.1007/s12098-016-2068-4. Epub 2016 Apr 7. Indian J Pediatr. 2016. PMID: 27053179
-
Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-epileptic Drugs.Front Neurol. 2018 Jul 13;9:579. doi: 10.3389/fneur.2018.00579. eCollection 2018. Front Neurol. 2018. PMID: 30057567 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
